Replies to post #23700 on Regen BioPharma Inc (RGBP)

[SidVicious]

On top of the financial shenanigans of Koos, let's remind the dear Regenologists on here the plan laid out by Landers.

From the PR:

Announce new partnerships or collaborations with academic, biotechnology and/or big pharma (Q1 2016)

IND response to the FDA comments for dCellVax (Q2 2016)

Initial IND submission to the FDA for inhibition of NR2F6 in an indication to be determined (Q2 2016)

Begin HemaXellerate clinical trial (Q3 2016)

Identify small molecule inhibitor of NR2F6 (Q3 2016)

Let's see what transpires this quarter. My bet we'll see academic collaborations which are nice but doesn't put money in Regen's pockets.

The one that would most likely move the pps up is a partnership with a well known pharma. Let's see if Landers can get that done.